Metallothionein induction protects swollen rat primary astrocyte cultures from methylmercury-induced inhibition of regulatory volume decrease

Brain Research

Volumn 738, Issue 2, 1996, Pages 213-221

  Vitarella, Domenico ^a   Conklin, Dawn R ^b   Kimelberg, Harold K ^a   Aschner, Michael ^b  

^a ALBANY MEDICAL COLLEGE   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

astrocyte; hypotonicity; metallothionein; methylmercury; regulatory volume decrease; taurine

Indexed keywords

METALLOTHIONEIN; METHYLMERCURY; TAURINE;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; ASTROCYTE; CELL CULTURE; CELL SWELLING; CONTROLLED STUDY; CYTOTOXICITY; IMMUNOBLOTTING; NEWBORN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CADMIUM CHLORIDE; CELL SIZE; CELLS, CULTURED; ELECTRIC IMPEDANCE; METALLOTHIONEIN; METHYLMERCURY COMPOUNDS; NERVE TISSUE PROTEINS; RATS; RATS, SPRAGUE-DAWLEY; TAURINE;

EID: 0030569335     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(96)00778-0     Document Type: Article

References (48)

1. [1] Ali, S.F., LeBel, C.P. and Bondy, S.C., Reactive oxygen species formation as a biomarker of methylmercury and trimethyltin neurotoxicity, Neurotoxicology, 13 (1992) 637-648.
2. [2] Aschner, M., The functional significance of brain metallothioneins, FASEB J., (1996) in press.
3. [3] Aschner, M., Eberle, N.B., Miller, K. and Kimelberg, H.K., Interactions of methylmercury with rat primary astrocyte cultures: inhibition of rubidium and glutamate uptake and induction of swelling, Brain Res., 530 (1990) 245-250.
4. [4] Blaauwgeers, H.G.T., Sillevis Smitt, P.A.E., DeJong, J.M.B.V. and Troost, D., Distribution of metallothionein in the human central nervous system, Glia, 8 (1993) 107-119.
5. 2 and methylmercury in astrocytes: selectivity and reversibility, J. Neurochem., 53 (1989) 1228-1237.
6. [6] Charleston, J.S., Body, R.L., Mottet, N.K., Vahter, M.E. and Burbacher, T.M., Autometallographic determination of inorganic mercury distribution in the cortex of the calcarine sulcus of the monkey Macaca fascicularis following long-term subclinical exposure to methylmercury and mercuric chloride, Toxicol. Appl. Pharmacol., 132 (1995) 325-333.
7. [7] Chen, R.W., Ganther, H.E. and Hoekstra, W.G., Studies on the binding of methylmercury by thionein, Biochem. Biophys. Res. Commun., 51 (1973) 383-390.
8. [8] Chmielnicka, I. and Brzeznicka, E.A., The influence of selenium on the level of mercury and metallothionein in rat kidneys in prolonged exposure to different mercury compounds, Bull. Environ. Contamin. Toxicol., 19 (1978) 183-190.
9. [9] Choudhuri, S., Kramer, K.K., Berman, N.E., Dalton, T.P., Andrews, G.K. and Klaassen, C.D., Constitutive expression of metallothionein genes in mouse brains, Toxicol. Appl. Pharmacol., 131 (1995) 144-154.
10. [10] Coogan, T.P., Bare, R.M., Bjornson, E.J. and Waalkes, E.J., Enhanced metallothionein gene expression is associated with protection from cadmium-induced genotoxicity in cultured rat liver cells, J. Toxicol. Environ. Health, 41 (1994) 233-245.
11. [11] Dunn, M.A., Blalock, T.L. and Cousins, R.J., Metallothionein, Proc. Soc. Exp. Biol. Med., 185 (1987) 107-119.
12. [12] Foulkes, B.C., Metallothionein and glutathione as determinants of cellular retention and extrusion of cadmium and mercury, Life Sci., 52 (1993) 1617-1620.
13. [13] Frangakis, M.V. and Kimelberg, H.K., Dissociation of neonatal rat brain by dispase for preparation of primary astrocyte cultures, Neurochem. Res., 9 (1984) 1689-1698.
14. [14] Ganther, H.E., Modification of methylmercury toxicity and metabolism by selenium and vitamin E: possible mechanisms, Environ. Health Perspect., 25 (1978) 71-76.
15. [15] Garman, R.H., Weiss, B. and Evans, H.L., Alkylmercurial encephalopathy in the monkey; a histopathologic and autoradiographic study, Acta Neuropathol., 32 (1975) 61-74.
16. [16] Goering, P.L. and Klaassen, C.D., Altered subcellular distribution of cadmium following cadmium pretreatment: possible mechanism of tolerance to cadmium-induced lethality, Toxicol. Appl. Pharmacol., 70 (1983) 195-203.
17. [17] Hamer, D.H., Metallothionein, Annu. Rev. Biochem., 55 (1986) 913-951.
18. [18] Hughes, W.H., A physiochemical rationale for the biological activity of mercury and its compounds, Ann. NY Acad. Sci., 65 (1957) 454-460.
19. [19] Kägi, J.H.R. and Schäffer, A., Biochemistry of metallothionein, Biochemistry, 27 (1988) 8509-8515.
20. [20] Kimelberg, H.K., Swelling and volume control in brain astroglial cells. In R. Gilles, E.K. Hoffmann and L. Bolis (Eds.), Comparative and Environmental Physiology, Springer-Verlag, New York, 1991, pp. 81-117.
21. 51Cr cell labeling to distinguish between release of radiolabeled amino acids from primary astrocyte cultures being due to efflux or cell damage, Brain Res., 622 (1993) 237-242.
22. [22] Koizumi, T., Yokota, T., Ohmori, S., Kumagai, H. and Suzuki, K.T., Protective effect of metallothionein on intracellular pH changes induced by cadmium, Toxicology, 95 (1995) 11-17.
23. [23] Laemmli, U.K., Cleavage of structural proteins during the assembly for the head of bacteriophage T4, Nature, 227 (1970) 680-685.
24. [24] Lane, L.C., A simple method for stabilizing protein-sulfhydryl groups during SDS-gel electrophoresis, Anal. Biochem., 86 (1978) 655-664.
25. [25] Leyshon-Sørland, K., Jasani, B. and Morgan, A.J., The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury, Histochem. J., 26 (1994) 161-169.
26. [26] Liu, J., Kershaw, W.C. and Klaassen, C.D., The protective effect of metallothionein on the toxicity of various metals in rat primary hepatocyte culture, Toxicol. Appl. Pharmacol., 107 (1991) 27-34.
27. [27] Liu, Y., Liu, J., Iszard, M., Andrews, G.K., Palmiter, R.D. and Klaassen, C.D., Transgenic mice that overexpress metallothionein-I are protected from cadmium lethality and hepatotoxicity, Toxicol. Appl. Pharmacol., 135 (1995) 222-228.
28. [28] Masters, B.A., Kelly, E.J., Quaife, C.J., Brinster, R.L. and Palmiter, R.D., Targeted disruption of metallothionein I and II genes increases sensitivity to cadmium, Proc. Natl Acad. Sci. USA, 91 (1994) 584-588.
29. [29] Mullaney, K.J., Fehm, M.N., Vitarella, D., Wagoner Jr., D.E. and Aschner, M., The role of -SH groups in methylmercuric chloride-induced D-aspartate and rubidium release from rat primary astrocyte cultures, Brain Res., 641 (1994) 1-9.
30. [30] O'Connor, E.R., Kimelberg, H.K., Keese, C.R. and Giaever, I., Electrical impedance method for measuring volume changes in astrocytes, Am. J. Physiol., 264 (1993) C471-C478.
31. [31] Oyake, Y., Tanaka, M., Kubo, H. and Cichibu, H., Neuropathological studies on organic mercury poisoning with special reference to the staining and distribution of mercury granules, Adv. Neural. Sci., 10 (1966) 744-750.
32. [32] Palmiter, R.D., Findley, S.D., Whitmore, T.E. and Durnam, D.M., MT-III, a brain specific member of the metallothionein gene family, Proc. Natl. Acad. Sci. USA, 89 (1992) 6333-6337.
33. [33] Pasantes-Morales, H., Alavez, S., Sanchez Olea, R. and Moran, J., Contribution of organic and inorganic osmolytes to volume regulation in rat brain cells in culture, Neurochem. Res., 18 (1993) 445-452.
34. [34] Pasantes-Morales, H. and Schousboe, A., Volume regulation in astrocytes: a role for taurine as an osmoeffector, J. Neurosci. Res., 20 (1988) 505-509.
35. [35] Quaife, C.J., Findley, S.D., Erickson, J.C., Froelick, G.J., Kelly, E.J., Zambrowicz, B.P. and Palmiter, R.D., Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia, Biochemistry, 33 (1994) 7250-7259.
36. r cells in response to lead treatment, Chem. Biol. Interact., 72 (1989) 347-361.
37. [37] Rising, L., Vitarella, D., Kimelberg, H.K. and Aschner, M., Metallothionein induction in neonatal rat primary astrocyte cultures protects against methylmercury cytotoxicity, J. Neurochem., 65 (1995) 1562-1568.
38. 2)-induced metallothionein (MT) expression in neonatal rat primary astrocyte cultures, Brain Res., 678 (1995) 91-98.
39. [39] Rothstein, A. and Mack, E., Actions of mercurials on cell volume regulation of dissociated MDCK cells, Am. J. Physiol., 260 (1991) C113-C121.
40. [40] Takeuchi, T., Morikawa, N., Matsumoto, H. and Shiraishi, A., A pathological study of Minamata disease, Acta Nenropathol., 2 (1962) 40-57.
41. [41] Towbin, H., Staehelin, T. and Gordon, J., Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications, Proc. Natl. Acad. Sci. USA, 76 (1979) 4350-4354.
42. [42] Uchida, Y., Takio, K., Titani, K., Ihara, Y. and Tomonaga, M., The growth inhibitory factor that is deficient in Alzheimer's disease is a 68 amino acid metallothionein-like protein, Neuron, 7 (1991) 337-347.
43. [43] Vahter, M.E., Mottet, N.K., Friberg, L.T., Lind, S.B., Charleston, J.S. and Burbacher, T.M., Demethylation of methyl mercury in different brain sites of Macaca fascicularis monkeys during long-term subclinical methylmercury exposure, Toxicol. Appl. Pharmacol., 134 (1995) 273-284.
44. [44] Vitarella, D., DiRisio, D., Kimelberg, H.K. and Aschner, M., Potassium and taurine release are highly correlated with regulatory volume decrease in neonatal primary rat astrocyte cultures, J. Neurochem., 63 (1994) 1143-1149.
45. + uptake, Brain Res., (1996) submitted.
46. [46] Weiner, B.J., Alternative procedures for making a posteriori tests. In B.J. Weiner (Ed.) Statistical Principles in Experimental Design, McGraw-Hill, New York, 1971, pp. 196-200.
47. [47] World Health Organization, Methylmercury, Environmental Health Criteria 101, World Health Organization, Geneva, 1990.
48. [48] Yee, S. and Choi, B.H., Methylmercury poisoning induces oxidative stress in the mouse brain, Exp. Mol. Pathol., 60 (1994) 188-196.